Picture of USANA Health Sciences logo

USNA — USANA Health Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesAdventurousSmall CapContrarian

USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance

USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance


Overview

  • Nutritional supplements maker's fiscal Q2 sales fell 5% yr/yr amid weaker Hiya and Rise performance

  • Company posted a net loss, including preliminary non-cash impairment charge related to Hiya

  • Fiscal 2026 outlook lowered for sales and earnings due to Hiya and Rise underperformance


Outlook

  • USANA cuts 2026 consolidated net sales outlook to $910 mln from $925 mln-$1.0 bln

  • Company lowers 2026 net (loss) earnings forecast to $(11) mln from $20 mln-$27 mln

  • USANA expects 2026 adjusted diluted EPS of $0.76, down from $1.95-$2.29 prior view


Result Drivers

  • HIYA WEAKNESS - Hiya's performance was pressured by a challenging digital marketing environment, impacting topline, subscriber growth, and margins

  • RISE WELLNESS DISRUPTION - Rise Wellness saw a packaging-related disruption that affected commercial execution during the quarter

  • IMPAIRMENT CHARGE - Co recorded a preliminary non-cash impairment charge for Hiya, reflecting recent performance and changes in near-term forecasts


Company press release: ID:nBw3tVm09a


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Miss

$223 mln

$235.003 mln (1 Analyst)

Q2 Loss Per Share

$1.16

Q2 Net Earnings

-$21.40 mln


Analyst Coverage

  • Wall Street's median 12-month price target for USANA Health Sciences Inc is $39.00, about 70.8% above its August 3 closing price of $22.84

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago


Reuters Recommended Reads

  • Aug 3 - Medifast Q2 revenue falls 28% as active coaches drop

  • Aug 4 - P&G buys supplements maker Thorne for $3.8 billion as wellness push intensifies

  • Aug 3 - QHSLab's Q2 revenue rises on ISP growth


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on USANA Health Sciences

See all news